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We would like to thank Tas¸olar et al. for their valuable
comments. They have raised some limitations. We agree with the
hypothesis that if the blood samples were collected from the left
atrium or coronary sinus, the atrial inﬂammation could be more
accurately evaluated [1]. According to our opinion, this type of
investigation may be conducted in patients who undergo catheter
ablation for atrial ﬁbrillation (AF), otherwise, it would necessitate
additional invasive strategy which may raise some ethical issues.
The association between risk of stroke and resistin levels have been
evaluated in multiple studies [2–5]. In the PRIME study, 9771
healthy men, aged 50 to 59 years old were followed up over 10
years which showed that serum resistin, adiponectin, and E-
selectin levels were associatedwith risk of stroke [5]. These studies
were conducted with large sample sizes and long-term follow-up.
Due to the small sample size and short follow-up period in this
study, stroke rate was not deﬁned as an end-point. As noted by the
authors, antidiabetic drugs may have an effect on resistin levels.
The total number of subjects with diabetes mellitus was 40 (25.3%)
in the study population and was not different between the control
and AF subjects and also between the AF subgroups. We have
reviewed the data of patients with diabetes mellitus and could not
identify any subject who had been treated with rosiglitazone.
Nevertheless, the effect of medications on resistin levels especially
in diabetic patients may be accepted as a limitation of the study.
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